Citation Impact
Citing Papers
miR-15 and miR-16 induce apoptosis by targeting BCL2
2005 Standout
Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
2013 Standout
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2009 Standout
Identification of a Small Interface between the Methyltransferase and RNA Polymerase of NS5 that is Essential for Zika Virus Replication
2018 StandoutNobel
Calcium-dependent Regulation of Protein Kinase D Revealed by a Genetically Encoded Kinase Activity Reporter
2006 StandoutNobel
Comprehensive analysis of CDKN2A (p16INK4A/p14ARF) and CDKN2B genes in 53 melanoma index cases considered to be at heightened risk of melanoma
2005
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Protein kinase D2 mediates lysophosphatidic acid-induced interleukin 8 production in nontransformed human colonic epithelial cells through NF-κB
2006
A Trial of Etanercept, a Recombinant Tumor Necrosis Factor Receptor:Fc Fusion Protein, in Patients with Rheumatoid Arthritis Receiving Methotrexate
1999 Standout
Circular RNAs are a large class of animal RNAs with regulatory potency
2013 StandoutNature
Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein–methyltransferase superfamily
2001
Tumoricidal activity of tumor necrosis factor–related apoptosis–inducing ligand in vivo
1999 Standout
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
2011 StandoutNature
Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation
2002 StandoutNature
BRAFE600-associated senescence-like cell cycle arrest of human naevi
2005 StandoutNature
Cellular Senescence in Cancer and Aging
2007 Standout
Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
1999 Standout
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
2011 StandoutNature
Heat Stroke
2002 Standout
The Bcl2 family: regulators of the cellular life-or-death switch
2002 Standout
Tumor necrosis factor receptors-structure and function
1992
Acute myeloid leukaemia
2006
Expression of Linear and Novel Circular Forms of an INK4/ARF-Associated Non-Coding RNA Correlates with Atherosclerosis Risk
2010
Hypermethylation of p16INK4a in Chinese lung cancer patients: biological and clinical implications
2003
Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis
2001 Standout
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
PPAR-γ agonists inhibit production of monocyte inflammatory cytokines
1998 StandoutNature
Cell-free nucleic acids as biomarkers in cancer patients
2011 Standout
Infliximab and Methotrexate in the Treatment of Rheumatoid Arthritis
2000 Standout
Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1989 StandoutNobel
Cytokine gene polymorphism in human disease: on-line databases
1999
Malignant Gliomas in Adults
2008 Standout
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia.
1994
INK4a/ARF: A multifunctional tumor suppressor locus
2005
Sickle-cell disease
2010 Standout
Non-coding RNAs in human disease
2011 Standout
Inflammation and cancer: back to Virchow?
2001 Standout
Free radicals and antioxidants in normal physiological functions and human disease
2006 Standout
The Emerging Hallmarks of Cancer Metabolism
2016 Standout
A Comparison of Etanercept and Methotrexate in Patients with Early Rheumatoid Arthritis
2000 Standout
Reactive oxygen species in cancer
2010 Standout
Primary brain tumours in adults
2012 Standout
Leukaemogenesis: more than mutant genes
2009
Molecular Genetic Pathways as Therapeutic Targets in Acute Myeloid Leukemia
2008
CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?
2011
Protein Kinase D Signaling
2005
Caspase-Dependent Cytosolic Release of Cytochrome c and Membrane Translocation of Bax in p53-Induced Apoptosis
2001
Concentrations of soluble tumor necrosis factor and interleukin-6 receptors in heatstroke and heatstress
1997
The Tumor Suppressor Protein p16 and the Human Papillomavirus Oncoprotein-58 E7 Are Naturally Occurring Lysine-less Proteins That Are Degraded by the Ubiquitin System
2004 StandoutNobel
TRADD–TRAF2 and TRADD–FADD Interactions Define Two Distinct TNF Receptor 1 Signal Transduction Pathways
1996 Standout
Mitochondrial ROS – radical detoxification, mediated by protein kinase D
2006
Identification of Cyclobutane Pyrimidine Dimer-Responsive Genes Using UVB-Irradiated Human Keratinocytes Transfected with In Vitro-Synthesized Photolyase mRNA
2015 StandoutNobel
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
2013
Both products of the mouse Ink4a/Arf locus suppress melanoma formation in vivo
2003
TNF ligands and receptors – a matter of life and death
2002
A Novel Tyrosine Phosphorylation Site in Protein Kinase D Contributes to Oxidative Stress-mediated Activation
2007
L‐asparaginase treatment in acute lymphoblastic leukemia
2010
Anemia of Chronic Disease
2005 Standout
The cancer genome
2009 StandoutNature
Interleukin-1 polymorphisms associated with increased risk of gastric cancer
2000 StandoutNature
Prognostic impact of WT1 mutations in cytogenetically normal acute myeloid leukemia: a study of the German-Austrian AML Study Group
2009
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Genome Regulation by Long Noncoding RNAs
2012 Standout
Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis
2000
TET2 deficiency leads to stem cell factor–dependent clonal expansion of dysfunctional erythroid progenitors
2018
TUMOR NECROSIS FACTOR: A Pleiotropic Cytokine and Therapuetic Target
1994
Identification and transcriptome analysis of erythroblastic island macrophages
2019 StandoutNobel
Rb-Mediated Heterochromatin Formation and Silencing of E2F Target Genes during Cellular Senescence
2003 Standout
Acute Myeloid Leukemia and Myelodysplastic Syndromes in Older Patients
2007
Complementary Sequence-Mediated Exon Circularization
2014 Standout
Non-A, non-B hepatitis. I. Recognition, epidemiology, and clinical features
1983
Conjugate of Pt(IV)–Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
2012
MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-β superfamily
1997 Standout
How I treat transfusional iron overload
2012
Cell cycle deregulation in B-cell lymphomas
2003
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
2003 Standout
Circadian Clock, Cancer, and Chemotherapy
2014 StandoutNobel
FREQUENT GENOTYPE CHANGES AT −308, AND 488 REGIONS OF THE TUMOR NECROSIS FACTOR-α (TNF-α) GENE IN PATIENTS WITH PROSTATE CANCER
2000
Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
1993 StandoutNobel
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies
2009
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Malignant glioma: genetics and biology of a grave matter
2001
The INK4a/ARF locus and melanoma
2003
Physiology of Microglia
2011 Standout
Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein
1997
Prognostic importance of serum soluble CD23 level in chronic lymphocytic leukemia
1996
Works of Mathias Schmid being referenced
[Non-A, non-B viral hepatitis: occurrence, epidemiology and prognosis].
1981
Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in hairy cell leukaemia
1997
The histone deacetylase (HDAC) inhibitor valproic acid as monotherapy or in combination with all‐trans retinoic acid in patients with acute myeloid leukemia
2005
Polymorphism of the tumour necrosis factor‐alpha and lymphotoxin‐alpha genes in chronic lymphocytic leukaemia
1997
Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes
2012
P53 mutations in hairy cell leukemia
2000
Liposomal cytarabine is effective and tolerable in the treatment of central nervous system relapse of acute lymphoblastic leukemia and very aggressive lymphoma
2010
Molecular Genetic Alterations in Radiation-Induced Astrocytomas
1999
A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer
2000
Altered Sensitivity to Retinoid-Induced Apoptosis Associated with Changes in the Subcellular Distribution of Bcl-2
1997
High levels of circulating soluble receptors for tumor necrosis factor in hairy cell leukemia and type B chronic lymphocytic leukemia.
1992
Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation
2005
Deferasirox in iron-overloaded patients with transfusion-dependent myelodysplastic syndromes: Results from the large 1-year EPIC study
2010
Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC)
1998
PEG-Asparaginase in Adult Acute Lymphoblastic Leukemia (ALL): Efficacy and Feasibility Analysis with Increasing Dose Levels
2008
Protein Kinase D2 Mediates Activation of Nuclear Factor κB by Bcr-Abl in Bcr-Abl+ Human Myeloid Leukemia Cells
2004
Valproic Acid as Adjunct to Induction Therapy in Patients with Acute Myeloid Leukemia: First Results of Two Randomized Studies of the AMLSG.
2005
CD44v6, a target for novel antibody treatment approaches, is frequently expressed in multiple myeloma and associated with deletion of chromosome arm 13q.
2005
Continued Low-Dose Decitabine (DAC) Is an Active First-Line Treatment of Older AML Patients: First Results of a Multicenter Phase II Study.
2005